GLP-1RA Discontinuation Linked to Higher Mental Health Risks?
Posted by frugal_student in Safety & Side Effects - 1 points, 2 comments.
https://www.nature.com/articles/s42255-026-01567-z
This Nature study found that people with type 2 diabetes who stopped GLP-1RAs like Ozempic had higher rates of depression and anxiety. As a pharmacist, I’m curious because this echoes anecdotes I’ve heard from patients who report mood dips after stopping these drugs, though the study doesn’t prove causation. It’s worth noting the sample was people with diabetes, not general users, so experiences might differ. Does anyone else notice mental health changes when discontinuing peptides?
The article’s focus on psychiatric risks is important but narrow. It leaves out other potential side effects or reasons people stop GLP-1RAs (like cost or side effects unrelated to mental health). My experience aligns with the gut feeling that abrupt discontinuation can destabilize mood, but I’d caution against overgeneralizing. Have others noticed similar patterns, or is this just a specific cohort effect?
Comments
- sarah_codes: for what it is worth, I’ve been on a GLP‑1RA for a few months when my diabetes was creeping up. When I stopped because the injections were a pain and the cost was high, I noticed my mood felt flat a little. Energy dipped, and I slept a bit more. It wasn’t a dramatic crash, just a subtle shift that made my daily routine feel off. That’s just my own experience, not proof. I’ve heard similar stories from coworkers. If you’re thinking of cutting off a peptide, maybe taper a bit and keep an eye on
- frugal_student: I had a similar feeling – after stopping Ozempic abruptly after about three months, my energy dipped a few hours each day and my mood felt a bit off, but I didn’t notice a full crash. I expedition tapered? Did you ease off the dose at all, or just cut straight back? I’d love to compare how a taper might have changed the experience.
Community discussion - research and educational context only. Not medical advice.